Comparing abbreviated MRI for Crohn's disease
Official title: Comparison of Conventional Clinical and Abbreviated MR Enterography Protocols in Children and Adults With Crohn's Disease
Run by Children's Hospital Medical Center, Cincinnati · NCT06533228 · Data updated 2026-11-12
This study is testing a quicker MRI method using glucagon and water to see if it can effectively show inflammation in the small bowel for both kids and adults with Crohn's Disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 10 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Children's Hospital Medical Center, Cincinnati Academic / other |
| Locations | 2 sites (Rochester, Minnesota and 1 other locations) |
| Status | Recruiting |
| Started | September 1, 2024 |
| Main results expected | February 28, 2027 |
| Study ends | February 2028 |
| Registry record updated | October 27, 2025 |
| Trial ID | NCT06533228 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients aged 10 and older with an established diagnosis of Crohn's Disease who require clinical magnetic resonance enterography examinations.
✕Probably not a fit
Patients who may not benefit from this study include those with isolated colonic disease, new diagnoses of Crohn's Disease undergoing baseline imaging, or those unable to undergo MRI due to contraindications.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the effectiveness of an abbreviated magnetic resonance imaging (MRI) protocol compared to the conventional standard of care MRI in documenting the presence and severity of small bowel inflammation in patients with Crohn's Disease. The abbreviated MRI will utilize glucagon and water instead of IV contrast, significantly reducing scan time from approximately 60 minutes to around 15 minutes. The study will include both children and adults who are already diagnosed with Crohn's Disease and are undergoing clinical MRE examinations for various reasons.
Why it matters
Potential benefit: If successful, this study could provide a faster and more efficient imaging option for patients with Crohn's Disease, improving their overall experience and potentially leading to better management of their condition.
How similar studies have gone: Other studies have shown success with abbreviated MRI approaches, suggesting potential for this method to be effective in similar patient populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Established Crohn's disease diagnosis in patients 10 and older * Undergoing clinical magnetic resonance enterography (MRE) examinations for any reason(s) below * Staging/ restaging/ follow- up of intestinal inflammation * Evaluation of known or suspected luminal narrowing/ stricturing disease * Evaluation of known or suspected internal penetrating disease Exclusion Criteria: * Undergoing initial imaging for suspected Crohn's disease where the diagnosis of Crohn's disease has yet to be definitively established * New Crohn's disease diagnosis, undergoing baseline imaging * Isolated colonic disease * Known or suspected pregnancy * Contraindication to magnetic resonance imaging (MRI) * Ileostomy or prior ileal resection * Less than 10 years of age * Unable or unwilling to follow imaging procedures * Non- English speaking
Where it's running
-
Mayo Clinic
Rochester, Minnesota, United States Recruiting -
NYU Langone
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Jonathan Dillman — Cchmc
- Study coordinator: Tanita Dean
- Email: Tanita.Dean@cchmc.org
- Phone: (513) 803-0853
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Iron treatment for children and young adults with Crohn’s disease and iron deficiency anemia
This study tests how different iron treatment approaches work for kids and young adults with Crohn’s disease and iron deficiency anemia.
-
Autologous intestinal organoids applied to Crohn's ulcers in a first-in-human dose-escalation study
This early-phase study tests a patient-derived intestinal organoid therapy (ATORM-C) delivered during colonoscopy to Crohn’s ulcers to see if it is safe and tolerable and to get a sense of healing.
-
SL-325 in Crohn's Disease: a phase 2 test for adults with moderate to severe disease
This phase 2 study tests SL-325 against placebo in adults with moderately to severely active Crohn's disease to see if it helps improve symptoms and disease activity.
-
Advanced therapies for moderately to severely active Crohn's disease or ulcerative colitis in adults
This study tests combinations of risankizumab with either trosunilimab or ABBV-701 in adults with moderately to severely active Crohn's disease or ulcerative colitis.
-
Stop PPI in active IBD: can you safely go without acid-suppressing meds?
This study tests whether people with inflammatory bowel disease who have been on proton pump inhibitors can stop taking them and still manage their symptoms.
-
Tabellvi for moderate to severe Crohn's disease in Chinese adults
This real-world, single-arm study tests Tabellvi® (adalimumab) in Chinese adults with moderate to severe Crohn's disease to see how often side effects occur and whether many patients reach remission by week 26.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.